RxDoctor Payments Data

Wendy Mitchell

Neurology with Special Qualifications in Child Neurology · Los Angeles, CANPI 1699859652

Payments from drug & device makers

What this record shows

This record is dominated by education: $10 of the $10 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Travere Therapeutics, Inc.. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in CA, where the typical reported total is $1,230.

$10in general payments, 2019–2025

Across 3 payments — averaging $3.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$10
$750,296in research payments, 2019–2025

Across 67 payments — averaging $11,198 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GW Research Limited$507K
  • Teva Pharmaceuticals USA, Inc.$79K
  • Eisai Inc.$46K
  • Pfizer$45K
  • AbbVie$38K
  • Biohaven Pharmaceutical Holding Company Ltd.$35K
  • plus $1K from 1 others

What the payments were for

  • Education$10100%

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Travere Therapeutics, Inc.3$10

How this compares

$10 in reported general payments places this provider in the 0th percentile of 216 neurology with special qualifications in child neurology providers in California.

See all neurology with special qualifications in child neurology providers in California

Other neurology with special qualifications in child neurology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →